recombinant oncolytic virus vaccine (AuRx)

N/A

Report date: 2025/03/20 09:39:04

Base Information

Drug Namerecombinant oncolytic virus vaccine (AuRx)
Drug Alias Namedelta PK vaccine (AuRx)AuRx Theracine
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurx
China Registration ClassN/A

Develop Information

Active CompaniesAurx
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A